Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E610109-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $60.90 | |
E610109-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $147.90 | |
E610109-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $392.90 | |
E610109-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $587.90 |
Synonyms | elzovantinib|TPX-0022|2271119-26-5|CSF1R-IN-2|Elzovantinib [INN]|TTY12Q00LY|UNII-TTY12Q00LY|TPX0022|Elzovantinib [WHO-DD]|ELZOVANTINIB [USAN]|TPX002|CHEMBL5095061|SCHEMBL20694441|GTPL11869|GLXC-26839|EX-A5131|NSC820832|s9620|AKOS040740444|NSC-820832|compo |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of colony stimulating factor 1 receptor;Inhibitor of MET proto-oncogene; receptor tyrosine kinase;Inhibitor of SRC proto-oncogene; non-receptor tyrosine kinase |
Product Description |
Elzovantinib (TPX-0022) is an oral-active inhibitor of SRC, MET and c-FMS, with IC50 values of 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively.
|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (11S)-16-amino-2-ethyl-6-fluoro-11-methyl-14-oxo-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaene-5-carbonitrile |
---|---|
INCHI | InChI=1S/C20H20FN7O2/c1-3-27-10-13-12(8-22)14(21)4-5-15(13)30-11(2)9-24-20(29)17-18(23)26-28-7-6-16(27)25-19(17)28/h4-7,11H,3,9-10H2,1-2H3,(H2,23,26)(H,24,29)/t11-/m0/s1 |
InChi Key | UUDPUQDMSHQSKH-NSHDSACASA-N |
Canonical SMILES | CCN1CC2=C(C=CC(=C2C#N)F)OC(CNC(=O)C3=C4N=C1C=CN4N=C3N)C |
Isomeric SMILES | CCN1CC2=C(C=CC(=C2C#N)F)O[C@H](CNC(=O)C3=C4N=C1C=CN4N=C3N)C |
Alternate CAS | 2271119-26-5 |
PubChem CID | 137455315 |
Molecular Weight | 409.42 |
CAS Registry No. | 2271119-26-5 |
---|---|
PubChem CID | 137455315 |
Enter Lot Number to search for COA:
Solubility | DMSO: 25 mg/mL (61.06 mM), sonification is recommended. |
---|